Skip to main content
. Author manuscript; available in PMC: 2016 Jul 4.
Published in final edited form as: J Viral Hepat. 2010 Dec 8;18(7):e167–e174. doi: 10.1111/j.1365-2893.2010.01410.x

Table 3.

Outcomes by sub-genotype and by PCR status on admission to study. Genotype was not associated with a difference in outcome but early clearance, defined as PCR negative on admission, was associated with much poorer survival

Subgroup/
outcome
Spontaneous
survivors
Death
or LTx
P-value
Genotype 1B 3 (75%) 1 (25%) 0.88
Genotype 1A 11 (78.6%) 3 (21.4%)
PCR+ 14 (77.8%) 4 (22.2%) 0.007
PCR− 1 (16.7%) 5 (83.3%)